6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Neural Pathways in Addiction
Addiction alters neural pathways in the brain, particularly those involved in reward, motivation, and decision-making. Repeated exposure to addictive substances or behaviors changes the structure and function of these pathways, making them more sensitive to cues associated with the addictive behavior. The brain regions most impacted by addiction include the mesolimbic dopamine system, prefrontal cortex, and amygdala. These changes result in impaired judgment, compulsive behavior, and an inability to control cravings. Over time, the individual may feel driven to continue using the substance or engaging in the behavior despite negative consequences. Neuroplasticity, or the brain's ability to adapt, plays a key role in recovery, as therapeutic interventions can help rewire these pathways toward healthier behaviors and coping mechanisms.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States